Imperial College Health Partners
Imperial College Health Partners is the NHS-designated Health Innovation Network for North West London, partnering NHS trusts, the NW London ICB, and universities to deliver innovation adoption, population health missions, and the Discover-NOW real-world evidence data hub.
- Company typePrivate
- Founded2012
- HeadquartersLondon, United Kingdom
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Imperial College Health Partners does
Imperial College Health Partners (ICHP) is a partnership organisation created by the NHS in 2012 and incorporated as Imperial College Health Partners Ltd in England. It is the designated Health Innovation Network for North West London and brings together eight NHS trusts, the NW London Integrated Care Board, Imperial College London, and Brunel University to support complex change across the local health and care system. Its mandate spans NHS transformation support, health tech innovator enablement, and mission-led programmes covering cardiovascular disease, children and young people's mental health, obesity, patient safety, and environmental sustainability, serving a catchment of more than 2.4 million residents.
ICHP's core technology asset is Discover-NOW, a health data research hub for real-world evidence hosted by the organisation and described as one of Europe's largest longitudinal linked-data sources. The team has built population health management tools on top of this and related NHS data assets, including the London Asthma Decision Support (LADS) Tool (2021) and the Pan-London Respiratory Dashboard (2022). More recent launches include the ICHP Build programme with Cogniss (2025) for no-code digital health solution development, the Innovation Associates Programme (June 2026) for NHS workforce engagement, and a Regulatory Sandbox and Regulatory Navigator partnership with fsub (June-July 2026) for MHRA/UKCA compliance support.
The business model is publicly commissioned rather than commercial. Core funding flows from NHS England and the Office for Life Sciences as the designated Health Innovation Network, with secondary income from joint working agreements with commercial organisations — particularly in connection with Discover-NOW. Innovator-facing services such as Innovation Surgeries are free under the Office for Life Sciences commission, while bespoke NHS engagements are delivered as professional services. Headcount is approximately 40, leadership is chaired by Sir Mark Walport with Dr Dominique Allwood as CEO, and the board was expanded in July 2026 with three new Non-Executive Directors.
Imperial College Health Partners firmographics
Firmographics- Name
- Imperial College Health Partners
- Legal name
- Imperial College Health Partners Ltd
- Website
- https://imperialcollegehealthpartners.com
- Company type
- Private
- Founded year
- 2012
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Imperial College Health Partners is the NHS-designated Health Innovation Network for North West London, partnering NHS trusts, the NW London ICB, and universities to deliver innovation adoption, population health missions, and the Discover-NOW real-world evidence data hub.
- Ownership category
- akta.pro rank
Imperial College Health Partners industry classification
Industry- Product category
- Health Innovation Network Services
- NAICS
- Colleges, Universities, and Professional Schools (6113)
- SIC
- Services-Health Services (8000), Services-Misc Health & Allied Services, Nec (8090)
- akta.pro primary industry
- Health Systems Strengthening & Universal Health Coverage (UHC) Partnerships (HLAJAOAL)
- akta.pro secondary industries
- Health Systems Strengthening & Global Health Technical Assistance (BPADAEAH), Health & Biomedical Research Universities (Academic Medical Center–Affiliated) (EDAHABAC)
Keywords
Where Imperial College Health Partners is headquartered
LocationHeadquarters
- HQ city
- London
- HQ country
- United Kingdom
- HQ region
- Europe
Offices2 records
Markets served
Imperial College Health Partners business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales
Revenue model
- NHS England Commissioning: Core funding from NHS England for delivering health innovation network services as the designated Health Innovation Network for North West London.
- Office for Life Sciences: Government funding from the Office for Life Sciences to deliver bespoke support for innovators, particularly innovations facilitating NW London missions.
- Joint Working Agreements: For some programmes of work, joint working agreements with commercial organisations, particularly relevant in their role as host of Discover-NOW health data research hub.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Freemium | Multi-year contract | Free innovator support services |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels7 records
Imperial College Health Partners product offering
Product offeringCore offering
Imperial College Health Partners is a partnership organisation created by the NHS to support complex change across the health and care sector across North West London. As the designated Health Innovation Network for NW London, ICHP delivers commissioned innovation support, consultancy and convening services to NHS organisations, while hosting the Discover-NOW health data research hub for real-world evidence generation and operating population health mission programmes (CVD, mental health, obesity, patient safety, sustainability).
Product overview
ICHP is a partnership organisation and designated Health Innovation Network for North West London, providing a broad range of consultancy and support services rather than a unified software product. Its portfolio includes Innovation Surgery sessions, the Innovation Associates Programme, ICHP Build programme, and the North West London Missions (covering CVD, mental health, obesity, patient safety, and sustainability). ICHP also operates the Discover-NOW health data research hub and the Patient Safety Collaborative. Technical outputs include the London Asthma Decision Support (LADS) Tool and Pan-London Respiratory Dashboard. Services are delivered through consulting engagements, workshops, and a network of innovation support ecosystem partners.
Differentiator
Problem solved
Functional benefit
Brands
- Discover-NOW: Health data research hub for real world evidence, hosted by ICHP
- North West London Patient Safety Collaborative
Products and services
- Innovation Surgery 60-minute deep-dive sessions for innovators to understand value propositions, identify needs, and receive advice on progressing through innovation journeys. Free to all innovators as part of the Office of Life Sciences commission.
- ICHP Innovation Associates Programme A new flagship programme launched by ICHP's Innovation Support Team to enable NHS staff across North West London to get involved in the health innovation landscape with a flexible gateway and no minimum time commitment.
- ICHP Build A fully funded programme launched in 2025 in partnership with Cogniss that helps turn local ideas into real NHS solutions through no-code digital health development.
- North West London Missions Mission-led approach focusing on defined North West London priorities including cardiovascular care, children and young people's mental health, obesity, patient safety, and environmental sustainability.
- Discover-NOW Health data research hub hosted by ICHP as the designated Health Innovation Network for North West London, providing one of Europe's largest longitudinal linked-data sources for real-world evidence generation.
- North West London Patient Safety Collaborative System-wide collaborative initiative focused on system safety, medicines safety, managing deterioration, and maternity and neonatal safety across North West London.
- CVD Champions Programme Clinical engagement programme focused on cardiovascular disease prevention, detection, and treatment optimisation across North West London.
- ICHP Innovation Exchange Support ecosystem connecting individual innovators, start-ups, SMEs, and health tech companies to NHS adoption pathways and implementation sites.
- London Asthma Decision Support (LADS) Tool Population health management tool launched in 2021 by ICHP using data-driven insights to improve asthma care, incorporating air pollution, prescribing, and inhaler technique data to understand carbon impact.
- Pan-London Respiratory Dashboard Respiratory population health dashboard launched in 2022 by ICHP, integrating QOF, HES, and ePACT2 prescribing data to track and compare key respiratory metrics including inhaler carbon impact.
- NHS Services Support Commissioned consultancy service offering NHS clients expert support across strategy, data insight, solution sourcing, change implementation, engagement, and communications.
Quantifiable outcome
- Hypertension case find campaign: 575 blood pressure readings recorded, 149 high blood pressure cases identified, 131 high-risk patients engaged
- +4 more outcomes
Companies that use Imperial College Health Partners
Customer profileNamed customers11 records
Segments5 records
Ideal customer profiles3 records
Imperial College Health Partners technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Imperial College Health Partners partnerships and signals
Strategic signalPartnerships
Eleven partnerships are on record, tiered core and minor.
- fsubcoreRegulatory technology partnership providing the Regulatory Navigator platform to ICHP's innovator community. The platform helps innovators understand UK MHRA regulation, develop compliance documentation, and build quality management foundations to ISO standards. Eleven innovators participated in initial pilot programme.
- CognisscorePartnership to deliver ICHP Build programme - a fully funded initiative helping to turn local ideas into real NHS solutions. Cogniss provides the platform and expertise for no-code digital health solution development.
- NHS North West London Integrated Care BoardcorePrimary commissioning and strategic partnership for health innovation delivery. ICHP serves as the innovation arm of NW London ICS, facilitating mission-led approach to research and innovation.
- NHS Providers (NW London NHS Trusts)corePartnership network including Imperial College Healthcare NHS Trust, Chelsea and Westminster Hospital NHS Foundation Trust, Central and North West London NHS Foundation Trust, The Hillingdon Hospitals NHS Foundation Trust, Royal Brompton & Harefield Hospitals, London North West Healthcare NHS Trust, Central London Community Healthcare NHS Trust, and West London NHS Trust.
- Academic Partners (Imperial College London, Brunel University)coreUniversity partnerships bringing academic expertise, research capabilities and innovation networks to support health and care transformation in NW London.
- UK PharmaScanminorPharmaceutical innovations database enabling submission to UK national horizon scanning organisations and NHS England for visibility and engagement.
- DigitalHealth.LondonminorLondon-focused digital health support providing cohorts of digital health companies with bespoke business support via competitive programmes.
- Health FoundryminorPhysical space and supportive ecosystem for digital health startups to create and adopt scalable digital health solutions.
- NIHR Health Tech Research CentresminorCentres of excellence in NHS organisations across England accelerating development of healthcare technologies.
- Office for Life SciencescoreGovernment body commissioning ICHP as Health Innovation Network for NW London. Provides funding and strategic direction for innovator support delivery.
- NHS Innovation Accelerator (NIA)minorPersonal development programme for individuals scaling innovations with existing evidence base, part of Accelerated Access Collaborative.
Scale indicators6 records
Recent moves6 records
Expansion highlights5 records
Imperial College Health Partners competitors and assessment
Company assessmentDirect peers
- UCLPartners: An Academic Health Science Network/HIN for North London with the same NHS-commissioned innovation and population health remit, similar partnership model with major London universities (UCL, Queen Mary, LSHTM) and NHS trusts. Direct overlap on innovator support, data platforms (Discover-Now has a structural counterpart in UCLPartners' data programmes) and ICS convening.
- Health Innovation Network (South London): The South London Health Innovation Network has a structurally identical mandate to ICHP: designated HIN status, NHS England/Office for Life Sciences commissioning, innovator support (Innovation Surgeries), and a portfolio of population health missions. It is the closest geographic and model-level peer, providing a clean comparison on commissioning size and programmatic scope.
- Health Innovation Research Alliance Northern Ireland (HIRANI): Northern Ireland's innovation/research alliance with broadly analogous convening role bridging universities, health providers and industry. Comparable in structure (though not direct comp on commissioning), and specifically relevant given ICHP's new Board NED is HIRANI's CEO — indicating formal linkage between these peer organisations.
- Oxford Academic Health Partners / Health Innovation Oxford & Thames Valley: A regional HIN/AHSN covering Oxfordshire and Thames Valley with strong university partnership ties (Oxford, Brookes) and a comparable mix of innovation adoption, real-world evidence, and ICS convening. Useful peer for benchmarking high-performing academic-anchored HINs.
- Health Innovation Manchester: Designated HIN for Greater Manchester operating the same NHS Commissioning + Office for Life Sciences model with associated real-world evidence assets (e.g., Greater Manchester Care Record). Closest region-level comparison point for regional designation, scale of mission programmes, and innovator uptake volumes.
- West Midlands Academic Health Science Network: Designated HIN for the West Midlands operating the same NHS England/Office for Life Sciences commissioner model with innovator support and population health missions. Comparable on multi-mission portfolio depth (mental health, maternity, patient safety) and regional convening role.
Others
- NHS Innovation Accelerator (NIA): National accelerator programme (Accelerated Access Collaborative) for scaling proven innovations across the NHS. Complementary rather than directly competing — ICHP funnels innovators to NIA — but operationally and conceptually adjacent as a national scaling and convening mechanism.
- DigitalHealth.London: London-focused digital health accelerator that delivers programmes to cohorts of digital health innovators with NHS access support. Strong operational overlap on the innovator side — explicitly a partner of ICHP — making it the most directly comparable London digital health support programme for innovation pipeline and access support.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
Imperial College Health Partners social profiles
Digital presenceImperial College Health Partners financial estimates
Financial estimateRevenue estimate
Valuation estimate
Imperial College Health Partners leadership team
Management profileNumber of profiles
Profiles19 records
Imperial College Health Partners funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Imperial College Health Partners M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Imperial College Health Partners
What does Imperial College Health Partners do?
Imperial College Health Partners is a partnership organisation created by the NHS to support complex change across the health and care sector across North West London. As the designated Health Innovation Network for NW London, ICHP delivers commissioned innovation support, consultancy and convening services to NHS organisations, while hosting the Discover-NOW health data research hub for real-world evidence generation and operating population health mission programmes (CVD, mental health, obesity, patient safety, sustainability).
Is Imperial College Health Partners a public or private company?
Imperial College Health Partners is a private company. It is classified as state government owned and is currently operating.
When was Imperial College Health Partners founded?
Imperial College Health Partners was founded in 2012. It employs 11 to 50 people.
Where is Imperial College Health Partners based?
Imperial College Health Partners is headquartered in London, United Kingdom, in the Europe region.
How does Imperial College Health Partners make money?
Three revenue lines are on record. NHS England Commissioning is the primary driver. The others are office for Life Sciences and joint Working Agreements.
Who are Imperial College Health Partners's main competitors?
Direct peers on record are UCLPartners, Health Innovation Network (South London), Health Innovation Research Alliance Northern Ireland (HIRANI), Oxford Academic Health Partners / Health Innovation Oxford & Thames Valley, Health Innovation Manchester and West Midlands Academic Health Science Network. Others are NHS Innovation Accelerator (NIA) and DigitalHealth.London.
Does Imperial College Health Partners have an API?
No public API is recorded for Imperial College Health Partners.
What industry is Imperial College Health Partners in?
Imperial College Health Partners's product category is Health Innovation Network Services. Its primary akta.pro industry code is HLAJAOAL, Health Systems Strengthening & Universal Health Coverage (UHC) Partnerships, with a secondary code of BPADAEAH, Health Systems Strengthening & Global Health Technical Assistance. Its NAICS code is 6113 and its SIC code is 8000.